Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FU673
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,196
Award facts
- Contract value 100% obligated
- $33,195.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,195.87 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on December 11, 2025, with an ultimate completion date of December 12, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceuticals and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and medical devices. As the incumbent prime vendor under the DLA's pharmaceutical supply program, the company demonstrates proven capability in fulfilling federal procurement requirements across multiple therapeutic domains. This particular order for Jardiance, a diabetes management medication, reflects the company's role in supporting the Defense Health Agency and other federal healthcare systems with essential pharmaceutical commodities through flexible and comprehensive contracting vehicles.
Quick answers
Who was awarded contract SPE2DR26FU673?
SPE2DR26FU673 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FU673 worth?
The government has obligated $33,196 on SPE2DR26FU673.
Is contract SPE2DR26FU673 an order under another contract?
Yes. SPE2DR26FU673 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU673 competed?
The extent of competition for SPE2DR26FU673 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award